| Primary |
| Epilepsy |
17.9% |
| Prophylaxis Of Neural Tube Defect |
17.9% |
| Bipolar Disorder |
12.8% |
| Depression |
6.4% |
| Borderline Personality Disorder |
5.1% |
| Breast Cancer |
5.1% |
| Hypertension |
5.1% |
| Prophylaxis Of Nausea And Vomiting |
5.1% |
| Hypothyroidism |
3.8% |
| Obsessive-compulsive Disorder |
3.8% |
| Chemotherapy |
2.6% |
| Drug Use For Unknown Indication |
2.6% |
| Hyperemesis Gravidarum |
2.6% |
| Bacterial Infection |
1.3% |
| Cerebrovascular Accident |
1.3% |
| Hypovitaminosis |
1.3% |
| Lipid Metabolism Disorder |
1.3% |
| Pain |
1.3% |
| Product Used For Unknown Indication |
1.3% |
| Toothache |
1.3% |
|
| Neonatal Tachypnoea |
11.4% |
| Patent Ductus Arteriosus |
11.4% |
| Ventricular Septal Defect |
9.1% |
| Faeces Discoloured |
6.8% |
| Neonatal Respiratory Distress Syndrome |
6.8% |
| Tethered Cord Syndrome |
6.8% |
| Hepatic Enzyme Increased |
4.5% |
| Oxygen Saturation Decreased |
4.5% |
| Peritoneal Adhesions |
4.5% |
| Polydactyly |
4.5% |
| Premature Rupture Of Membranes |
4.5% |
| Somnolence |
4.5% |
| Withdrawal Syndrome |
4.5% |
| Hyperemesis Gravidarum |
2.3% |
| Jaundice |
2.3% |
| Product Substitution Issue |
2.3% |
| Pulmonary Artery Stenosis Congenital |
2.3% |
| Purpura |
2.3% |
| Skin Malformation |
2.3% |
| Vomiting |
2.3% |
|
| Secondary |
| Epilepsy |
29.8% |
| Convulsion |
16.2% |
| Drug Use For Unknown Indication |
8.1% |
| Pain |
5.6% |
| Borderline Personality Disorder |
4.5% |
| Prophylaxis Of Neural Tube Defect |
4.5% |
| Prophylaxis Of Nausea And Vomiting |
4.0% |
| Hypothyroidism |
3.5% |
| Breast Cancer |
3.0% |
| Product Used For Unknown Indication |
3.0% |
| Chemotherapy |
2.0% |
| Hypertension |
2.0% |
| Lipids Abnormal |
2.0% |
| Thrombosis |
2.0% |
| Vitamin Supplementation |
2.0% |
| Bacterial Infection |
1.5% |
| Bipolar Disorder |
1.5% |
| Drug Abuse |
1.5% |
| Foetal Exposure Timing Unspecified |
1.5% |
| Obsessive-compulsive Disorder |
1.5% |
|
| Convulsion |
14.8% |
| Premature Rupture Of Membranes |
11.1% |
| Neonatal Respiratory Distress Syndrome |
7.4% |
| Portal Vein Thrombosis |
7.4% |
| Pulmonary Artery Stenosis Congenital |
7.4% |
| Tachycardia |
7.4% |
| Withdrawal Syndrome |
7.4% |
| Abortion Late |
3.7% |
| Exposure During Pregnancy |
3.7% |
| Malaise |
3.7% |
| Neonatal Tachypnoea |
3.7% |
| Oxygen Saturation Decreased |
3.7% |
| Patent Ductus Arteriosus |
3.7% |
| Polydactyly |
3.7% |
| Shone Complex |
3.7% |
| Visual Impairment |
3.7% |
| Vomiting |
3.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.3% |
| Epilepsy |
16.5% |
| Hypertension |
6.0% |
| Multiple Sclerosis |
4.9% |
| Prophylaxis |
3.8% |
| Schizophrenia |
3.8% |
| Convulsion |
2.6% |
| Depression |
2.6% |
| Eczema |
2.3% |
| Nervous System Disorder |
2.3% |
| Rheumatoid Arthritis |
2.3% |
| Contraception |
1.9% |
| Crohn's Disease |
1.9% |
| Tuberous Sclerosis |
1.9% |
| Anxiety Disorder |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Dyspnoea |
1.5% |
| Partial Seizures |
1.5% |
| Psychotic Disorder |
1.5% |
| Schizoaffective Disorder |
1.5% |
|
| Syncope |
16.0% |
| Restless Legs Syndrome |
8.0% |
| Urinary Tract Infection |
8.0% |
| Night Sweats |
6.0% |
| Status Epilepticus |
6.0% |
| Urinary Hesitation |
6.0% |
| White Blood Cell Count Increased |
6.0% |
| Drug Abuse |
4.0% |
| Drug Ineffective |
4.0% |
| Myalgia |
4.0% |
| Pulmonary Embolism |
4.0% |
| Speech Disorder |
4.0% |
| Suicidal Ideation |
4.0% |
| Suicide Attempt |
4.0% |
| Tremor |
4.0% |
| Weight Decreased |
4.0% |
| Antipsychotic Drug Level Increased |
2.0% |
| Cholecystitis |
2.0% |
| Constipation |
2.0% |
| Convulsion |
2.0% |
|
| Interacting |
|
|
